Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Jan;59(1):8-10.

Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City

I Romieu  1 , J J Sienra-Monge, M Ramírez-Aguilar, H Moreno-Macías, N I Reyes-Ruiz, B Estela del Río-Navarro, M Hernández-Avila, S J London
Affiliations
Clinical Trial

Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City

I Romieu et al. Thorax. 2004 Jan.

Abstract

Background: We recently reported that antioxidant supplementation with vitamins C and E mitigated ozone related decline in forced expiratory flow (FEF(25-75)) in 158 asthmatic children in an area with high ozone exposure in Mexico City.

Methods: A study was undertaken to determine whether deletion of glutathione S-transferase M1 (GSTM1 null genotype), a gene involved in response to oxidative stress, influences ozone related decline in FEF(25-75) and the benefit of antioxidant supplementation.

Results: GSTM1 null children receiving placebo had significant ozone related decrements in FEF(25-75) (percentage change per 50 ppb of ozone 2.9 (95% CI -5.2 to -0.6), p=0.01); GSTM1 positive children did not. Conversely, the effect of antioxidants was stronger in children with the GSTM1 null genotype.

Conclusions: Asthmatic children with a genetic deficiency of GSTM1 may be more susceptible to the deleterious effects of ozone on the small airways and might derive greater benefit from antioxidant supplementation.

PubMed Disclaimer

Comment in

References

    1. Crit Rev Biochem Mol Biol. 1995;30(6):445-600 - PubMed
    1. Am J Epidemiol. 2000 Jan 1;151(1):7-32 - PubMed
    1. Mol Aspects Med. 2000 Feb-Apr;21(1-2):1-48 - PubMed
    1. Toxicol Lett. 2002 Aug 5;134(1-3):219-25 - PubMed
    1. Am J Respir Crit Care Med. 2002 Sep 1;166(5):703-9 - PubMed

Publication types